Literature DB >> 23231859

The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy.

M Unemo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23231859     DOI: 10.2807/ese.17.47.20323-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  8 in total

1.  Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.

Authors:  Andrea Endimiani; Yuvia N Guilarte; Regula Tinguely; Lea Hirzberger; Sylvia Selvini; Agnese Lupo; Christoph Hauser; Hansjakob Furrer
Journal:  BMC Infect Dis       Date:  2014-02-25       Impact factor: 3.090

2.  Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: the Washington State community-level randomized trial of EPT.

Authors:  Matthew R Golden; Roxanne P Kerani; Mark Stenger; James P Hughes; Mark Aubin; Cheryl Malinski; King K Holmes
Journal:  PLoS Med       Date:  2015-01-15       Impact factor: 11.069

3.  Gonorrhoea Diagnostic and Treatment Uncertainties: Risk Factors for Culture Negative Confirmation after Positive Nucleic Acid Amplification Tests.

Authors:  Rebecka Vyth; Amy Leval; Björn Eriksson; Eva-Lena Ericson; Lena Marions; Maria-Pia Hergens
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

4.  [From surveillance to action: Modifying therapeutic behaviours in gonococcal infections].

Authors:  María Jesús Purriños-Hermida; Isabel Losada Castillo; Ánxela Pousa Ortega; Óscar Paz Montero; Elvira Amado Fernández; Alberto Malvar Pintos
Journal:  Aten Primaria       Date:  2019-06-01       Impact factor: 1.137

Review 5.  Looking at the positives: proactive management of STIs in people with HIV.

Authors:  Carole Khaw; Daniel Richardson; Gail Matthews; Tim Read
Journal:  AIDS Res Ther       Date:  2018-12-21       Impact factor: 2.250

6.  Evaluation of Drugs with Therapeutic Potential for Susceptibility of Neisseria Gonorrhoeae Isolates from 8 Provinces in China from 2018.

Authors:  Xiao-Li Zheng; Wen-Qi Xu; Jing-Wei Liu; Xiao-Yu Zhu; Shao-Chun Chen; Yan Han; Xiu-Qin Dai; Isabelle Griffin Goodman; Christoph Budjan; Xiang-Sheng Chen; Yue-Ping Yin
Journal:  Infect Drug Resist       Date:  2020-12-15       Impact factor: 4.003

Review 7.  Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.

Authors:  Rui-xing Yu; Yueping Yin; Guan-qun Wang; Shao-chun Chen; Bing-jie Zheng; Xiu-qin Dai; Yan Han; Qi Li; Guo-yi Zhang; Xiangsheng Chen
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

8.  Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.

Authors:  Helen Kovari; Maria Dg de Melo Oliveira; Paula Hauser; Severin Läuchli; Jürg Meyer; Rainer Weber; Reinhard Zbinden
Journal:  BMC Infect Dis       Date:  2013-12-26       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.